France HADRON: national infrastructure for hadrontherapy research including ETOILE, ARCHADE and protontherapy centers - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Communication Dans Un Congrès Année : 2014

France HADRON: national infrastructure for hadrontherapy research including ETOILE, ARCHADE and protontherapy centers

Résumé

Hadrontherapy is an advanced form of radiotherapy able to cure very radioresistant tumors. It is developing since two decades mainly in Japan and Europe in Germany, Italy and Austria. The input of CERN has been important in its development in Europe. France is involved in that domain since 20 years thanks to its two protontherapy centers, ICPO in Orsay and Médicyc in Nice. This experience as well as the exploratory development of carbon ion therapy in the U.S.A., and the further clinical use in Japan and Europe, have given rise to projects in France for both a treatment center (ETOILE in Lyon) and a research center (ARCHADE in Caen). Different applied research programs have been associated to these projects involving many different teams located in different towns in France.
Fichier non déposé

Dates et versions

hal-01052734 , version 1 (28-07-2014)

Identifiants

  • HAL Id : hal-01052734 , version 1

Citer

J. Balosso, J.L. Habrand, Gerard Montarou, R. Ferrand, D. Dauvergne. France HADRON: national infrastructure for hadrontherapy research including ETOILE, ARCHADE and protontherapy centers. ICTR-PHE 2014, Feb 2014, Genève, Switzerland. ⟨hal-01052734⟩
169 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More